Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. / Kielgast, Urd; Asmar, Meena; Madsbad, Sten; Holst, Jens Juul.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 5, 2010, p. 2492-6.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kielgast, U, Asmar, M, Madsbad, S & Holst, JJ 2010, 'Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 5, pp. 2492-6. https://doi.org/10.1210/jc.2009-2440

APA

Kielgast, U., Asmar, M., Madsbad, S., & Holst, J. J. (2010). Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. Journal of Clinical Endocrinology and Metabolism, 95(5), 2492-6. https://doi.org/10.1210/jc.2009-2440

Vancouver

Kielgast U, Asmar M, Madsbad S, Holst JJ. Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. Journal of Clinical Endocrinology and Metabolism. 2010;95(5):2492-6. https://doi.org/10.1210/jc.2009-2440

Author

Kielgast, Urd ; Asmar, Meena ; Madsbad, Sten ; Holst, Jens Juul. / Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 5. pp. 2492-6.

Bibtex

@article{1b1a4a189cd444de86747f34c4d22a62,
title = "Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients",
abstract = "The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.",
keywords = "Arginine, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 1, Glucagon, Glucagon-Like Peptide 1, Glucagon-Secreting Cells, Humans, Hyperglycemia, Insulin-Secreting Cells, Serum Albumin",
author = "Urd Kielgast and Meena Asmar and Sten Madsbad and Holst, {Jens Juul}",
year = "2010",
doi = "10.1210/jc.2009-2440",
language = "English",
volume = "95",
pages = "2492--6",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients

AU - Kielgast, Urd

AU - Asmar, Meena

AU - Madsbad, Sten

AU - Holst, Jens Juul

PY - 2010

Y1 - 2010

N2 - The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.

AB - The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin is a necessary factor for this effect.

KW - Arginine

KW - Blood Glucose

KW - C-Peptide

KW - Diabetes Mellitus, Type 1

KW - Glucagon

KW - Glucagon-Like Peptide 1

KW - Glucagon-Secreting Cells

KW - Humans

KW - Hyperglycemia

KW - Insulin-Secreting Cells

KW - Serum Albumin

U2 - 10.1210/jc.2009-2440

DO - 10.1210/jc.2009-2440

M3 - Journal article

C2 - 20207828

VL - 95

SP - 2492

EP - 2496

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -

ID: 33940000